CYTOGENETIC AND GENOME RESEARCH is a pivotal journal dedicated to the exploration of cytogenetics, genomics, and their applications within clinical genetics and molecular biology. Published by KARGER in Switzerland, this journal aims to foster comprehensive discussions and disseminate impactful research from diverse fields related to genetics. It operates under an open access model, ensuring that researchers, professionals, and students can easily access and contribute to the latest findings. With coverage spanning from 1962 to 2024, CYTOGENETIC AND GENOME RESEARCH continues to serve as a vital resource, despite its current categorization in the Q4 quartile across Genetics and Molecular Biology. It provides an avenue for advancing the understanding of genomic mechanisms and their implications for human health. The journal encourages submissions that delve into cutting-edge methodologies, data interpretation, and theoretical frameworks, thereby playing a crucial role in the advancement of genetic research and its clinical applications.

GENOMICS PROTEOMICS & BIOINFORMATICS, published by Elsevier, stands at the forefront of cutting-edge research in the fields of genomics, proteomics, and bioinformatics. This esteemed journal, with an impact factor reflecting its significant influence, has embraced an Open Access model since its inception in 2003, ensuring that knowledge is freely accessible to a global community of researchers, professionals, and students. Based in China, it has been recognized for its exemplary contributions, achieving Q1 quartile rankings in major categories such as Biochemistry, Computational Mathematics, Genetics, and Molecular Biology as of 2023. Moreover, its commendable Scopus rankings position it among the top journals in its fields, with outstanding percentile performances that highlight its scholarly impact. As it continues to converge from 2003 to 2024, the journal aims to foster innovation and collaboration, making it an essential platform for disseminating vital insights and advancements in molecular life sciences.

Frontiers in Genome Editing, published by FRONTIERS MEDIA SA, stands at the forefront of genomic research, specializing in the rapidly evolving realm of gene editing technologies. With an enthusiastic commitment to open access since 2020, this journal facilitates unrestricted distribution of cutting-edge research, making significant advancements in biotechnology and genetics accessible to a global audience. Located in Lausanne, Switzerland, Frontiers in Genome Editing publishes high-quality, peer-reviewed articles that contribute to the understanding and application of genome editing tools, such as CRISPR and TALEN, in various biological fields. Notably, as of 2023, the journal holds a prestigious Q1 ranking in Biotechnology and a Q2 ranking in Genetics, underscoring its importance and influence within these disciplines. With robust Scopus rankings, including a notable percentile placement, Frontiers in Genome Editing is an invaluable resource for researchers, professionals, and students dedicated to the promising future of genomic innovation.

CHROMOSOME RESEARCH is a prestigious academic journal dedicated to advancing the field of genetics, published by SPRINGER. Operative since 1993, this journal is widely recognized for its contributions to the understanding of chromosomal dynamics, genetic interactions, and molecular biology, maintaining a significant impact factor that places it in the Q2 category within its field as of 2023. Despite being a non-open access publication, CHROMOSOME RESEARCH provides essential insights and peer-reviewed articles that are invaluable to researchers, professionals, and students alike, with continual publication through the convergence years stretching towards 2024. Furthermore, with a Scopus rank of #187 out of 347 in the Genetics category, it resides in the 46th percentile, epitomizing its relevance and scholarly rigor within the scientific community. For those engaged in the intricate study of genetics and chromosomal studies, CHROMOSOME RESEARCH remains a crucial resource for disseminating pivotal research findings and facilitating academic discourse.

Mitochondrial DNA Part B-Resources, published by TAYLOR & FRANCIS LTD, is a prominent academic journal focusing on the vast and evolving field of genetics and molecular biology. As an open access resource, it is dedicated to providing valuable insights and comprehensive data on mitochondrial DNA, an area crucial for understanding cellular functions, genetic inheritance, and various diseases. Although relatively new, having commenced in 2016, the journal has gained recognition with its current Scopus rankings placing it in the lower quartiles for both Genetics and Molecular Biology. It serves as an essential platform for researchers, professionals, and students at the intersection of genetics and biotechnology, fostering collaboration and innovation. With a commitment to quality research and accessibility, Mitochondrial DNA Part B-Resources is poised to contribute significantly to the scientific community until at least 2024 and beyond.

DNA RESEARCH is a pioneering open-access journal published by Oxford University Press, dedicated to advancing the field of genetics and molecular biology. Since its inception in 1994, the journal has been at the forefront of scientific innovation, providing a global platform for researchers to publish high-quality findings that drive the understanding of DNA and its implications in medicine. With an impactful presence characterized by a Q2 ranking in Genetics, a Q1 ranking in Medicine (miscellaneous), and a Q2 ranking in Molecular Biology as per the latest 2023 assessments, DNA RESEARCH stands as a vital resource for both established scholars and emerging scientists. The journal's diverse range of articles caters to a wide audience, fostering collaboration and the sharing of knowledge. Researchers, professionals, and students alike will find an abundance of cutting-edge research and insights that can inform their work and further their understanding of this critical scientific domain. For more information and to access articles, visit the journal's website at Oxford University Press.

G3-Genes Genomes Genetics is a prominent open access journal published by Oxford University Press, Inc., dedicated to advancing the field of genetics and genomics. Since its inception in 2011, the journal has become a vital resource for researchers, professionals, and students, featuring high-quality, peer-reviewed articles that cover a broad spectrum of topics within genetics, including clinical genetics and molecular biology. With an impressive standing reflected in its 2023 Scopus rankings, which positions it in the Q2 category for Genetics (Clinical) and Q1 for Medicine (Miscellaneous), G3 remains at the forefront of scholarly communication in these disciplines. The journal's commitment to open access ensures that cutting-edge research is accessible to a global audience, stimulating collaboration and innovation in the field. For those eager to explore the latest in genetic research, G3 serves as an indispensable platform, inviting contributions that push the boundaries of scientific understanding.

MAMMALIAN GENOME is a leading journal in the field of genetics, aimed at advancing our understanding of the genetic makeup and evolutionary relationships of mammals. Published by Springer, this journal has been a cornerstone resource since its inception in 1991, converging extensive research up to 2024. With a commendable Q2 classification in the 2023 Genetics category and a Scopus Rank of #208 out of 347, it serves as a vital platform for sharing cutting-edge findings, methodologies, and reviews pertaining to mammalian genomes. Although not an open-access journal, MAMMALIAN GENOME ensures that its content is accessible through institutional subscriptions, catering to a global audience of researchers, professionals, and students. Its commitment to excellence in genetic research positions it as an essential publication for anyone striving to contribute to this dynamic field.

RUSSIAN JOURNAL OF GENETICS is a significant platform in the field of genetics, published by PLEIADES PUBLISHING INC since its inception in 1996. With an ISSN of 1022-7954 and an E-ISSN of 1608-3369, the journal focuses on a wide array of topics within genetics, providing researchers, professionals, and students with insights into advancements and discoveries in this ever-evolving discipline. While it currently holds a Q4 ranking in the 2023 Genetics category according to Scopus, representing invaluable opportunities for knowledge dissemination, the journal is actively working to enhance its impact in future rankings. Readers will find the journal a repository of diverse genetic research findings, methodologies, and theoretical advancements. Although it is not an open-access journal, it is committed to serving the academic community through rigorous peer-reviewed articles. With a consistent publication trajectory spanning to 2024, the RUSSIAN JOURNAL OF GENETICS remains a crucial resource for those aspiring to stay at the forefront of genetic research and applications.

FUNCTIONAL & INTEGRATIVE GENOMICS, published by Springer Heidelberg, is a leading journal in the fields of genetics and molecular biology. Established in 2000, it serves as a pivotal platform for advancing our understanding of genomic functionality and integration, making significant contributions to both basic and applied research in genetics. With a robust impact factor and a ranking in the Q3 quartile for Genetics and Q2 for Medicine (Miscellaneous), the journal aims to publish innovative research that explores the relationships between genomic data and biological functions, appealing to a diverse audience of researchers and professionals. Although it operates under a subscription model, the journal's extensive archives remain a valuable resource for academics seeking to stay abreast of the latest findings and methodologies in genomics. As the field evolves, FUNCTIONAL & INTEGRATIVE GENOMICS remains committed to fostering scholarly dialogue and the dissemination of groundbreaking studies that influence future research trajectories.